Company intelligence / Profile preview
Wakamoto Pharmaceutical
Tokyo, Tokyo, Japanwakamoto-pharm.co.jp ↗
- Ownership
- Private
- Employees
- ~403
- Development stage
- Other
01
Overview
Wakamoto Pharmaceutical has a long history in Japan as a pioneer in self-medication and gastrointestinal health. Its flagship product "Strong Wakamoto" is an OTC probiotic/enzyme supplement for digestive health. The company also develops and markets prescription ophthalmology drugs and recently entered into licensing agreements to bring intraocular lens products to Japan. Several of its products are approved and commercially available in Japan[2][3][5][7].
- Therapeutic areas
- OphthalmologyImmunologyInfectious Diseases
- Modalities
- Small moleculeProbioticsEnzyme-based therapy
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
VSY Biotechnology GmbH – licensing agreement for intraocular lens products in Japan[5]
Beyond the preview
Go deeper on Wakamoto Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wakamoto Pharmaceutical.